Futurum Ventures
Inndalsveien 7B, Trondheim, 7047, Norway
Overview
Futurum Ventures invest in visionary entrepreneurs build and scale tech companies.
- Total investments
- 8
- Lead investments
- 2
- Investments · 12mo
- 5
- Active investors
- 4
Investment portfolio
- 3LC
Led · Safe · Aug 2026
Founded in 2023 with teams in the U.S. and Norway, 3LC positions itself in the emerging category of data-centric AI for physical systems and robotics (Physical AI). The company offers tools and processes to identify and prioritize the training data that most improves AI models while keeping data within customers' own infrastructure. Commercial traction accelerated through 2026, with customers and partners including Equinor, Mitsubishi (following a pilot and subsequent license), Syngenta, Brambles, Esmart Systems and Roboxi. 3LC has been building its U.S. commercial team, hiring personnel in Boulder, Colorado to handle onboarding and customer projects and to lead marketing and communications. Financially, the company has raised a SAFE round of $4.3 million and earlier convertible funding, bringing total capital raised to more than $8 million as it prepares for a Series A.
- Biosort
Participated · Equity · Mar 2026
Biosort is an Oslo-based aquaculture technology company focused on improving salmon farming through automated, data-driven tools. Its flagship platform, iFarm, identifies and tracks individual salmon inside sea pens, enabling farmers to monitor health and growth in real time. Building on this capability, the firm has engineered a complementary lice-control system that targets and removes sea lice at an early stage, aiming to curb infestations before they require large-scale wellboat treatments. Management claims the approach will enhance fish welfare, lower mortality, and reduce operational costs tied to lice mitigation. The newly raised capital will fund the final development steps and initial commercial roll-out of the lice-removal technology, which will be tightly integrated with iFarm. While no revenue or deployment figures were disclosed, the company positions this round as the bridge from R&D to commercial sales, indicating an imminent shift toward scaled market adoption.
- Spoor
Participated · Series A · Dec 2025
Founded in 2020 and based in Oslo, Spoor has developed patented computer-vision models that work with off-the-shelf cameras to detect, classify and track birds and bats at species level from long range. Its system integrates directly into wind-farm control architectures, enabling automated mitigation and shutdown-on-demand workflows required by new biodiversity mandates. Leveraging a database of more than one million bird observations and 200,000 hours of video footage, the product can survey up to 100 times more airspace per camera than conventional solutions, delivering faster and lower-cost deployments. Spoor already holds contracts across the project lifecycle with over 20 tier-one customers such as Ørsted, RWE, Vattenfall, TotalEnergies and Equinor. The company employs 22 people and plans to expand head-count in sales, engineering and deployment following its recent financing. Management intends to deepen integrations with wind-farm control systems and support global scaling as installed wind capacity is projected to rise from 1.3 TW today to 2.1 TW by 2030. Spoor’s investors include SET Ventures, EnBW New Ventures, Ørsted Ventures, Superorganism, Futurum Ventures and the Norwegian state climate fund Nysnø.
- Noteless
Participated · Seed · Nov 2025
Founded in October 2023 and based in Oslo, Noteless offers an AI scribe that leverages advanced speech recognition and natural language processing to create medical notes during patient consultations. The platform is designed to save clinicians up to two hours each day, easing administrative strain and allowing more time for patient care and personal well-being. Since launching its first product in June 2024, the company’s paying customer base has grown by more than 360 percent. Adoption is especially strong in the Nordics, with over one in four general practitioners in Norway and one in seven in Denmark using the tool. The product is also gaining traction among specialist doctors, physiotherapists, and psychologists. With fresh capital, Noteless plans to broaden its reach across Europe while continuing to enhance its AI technology and support high-quality patient care.
- Bislab
Led · Equity · Aug 2025
Bislab has developed a platform for credit and risk assessment that it says is significantly more accurate than incumbent solutions. The company counts customers such as Intrum, Tietoevry and BankID-selskapet Stø. Founders Martin Holten and Ole Kristian Haug report that their technology has helped clients reduce the number of credit-check rejections by over 60% without increasing risk. The startup plans to use new capital to expand across the Nordics and to build a larger technology organization, with a likely doubling of headcount during the year. Management says the raise will provide enough runway to reach profitability, though the near-term focus remains on growth rather than profit.